Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal Cancer

Annals of Surgical Oncology

Volumn 22, Issue 3, 2015, Pages 931-937

  Buchs, Nicolas C ^a   Ris, Frédéric ^a   Majno, Pietro E ^a,b   Andres, Axel ^a   Cacheux, Wulfran ^a   Gervaz, Pascal ^a   Roth, Arnaud D ^a,b   Terraz, Sylvain ^a,b   Rubbia Brandt, Laura ^a,b   Morel, Philippe ^a,b   Mentha, Gilles ^a,b   Toso, Christian ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hepato pancreato biliary Centre   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; LIVER METASTASIS; LIVER RESECTION; LONG TERM SURVIVAL; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE ILEUS; PREOPERATIVE RADIOTHERAPY; PYREXIA IDIOPATHICA; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; WOUND DEHISCENCE; ADENOCARCINOMA; CANCER STAGING; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RECTAL NEOPLASMS; SECONDARY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84924979780     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4069-8     Document Type: Article

References (29)

1. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–9.
2. Lemmens VE, de Haan N, Rutten HJ, Martijn H, Loosveld OJ, Roumen RM, et al. Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008. Clin Exp Metastasis. 2011;28:283–90.
3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982–99.
4. Vigano L, Karoui M, Ferrero A, Tayar C, Cherqui D, Capussotti L. Locally advanced mid/low rectal cancer with synchronous liver metastases. World J Surg. 2011;35:2788–95.
5. Julien LA, Thorson AG. Current neoadjuvant strategies in rectal cancer. J Surg Oncol. 2010;101:321–6.
6. Slesser AA, Bhangu A, Brown G, Mudan S, Tekkis PP. The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma. Tech Coloproctol. 2013;17:1–12.
7. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al. “Liver first” approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430–5.
8. Gervaz P, Rubbia-Brandt L, Andres A, Majno P, Roth A, Morel P, et al. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes. Ann Surg Oncol. 2010;17:2714–9.
9. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006;93:872–8.
10. Mentha G, Terraz S, Andres A, Toso C, Rubbia-Brandt L, Majno P. Operative management of colorectal liver metastases. Semin Liver Dis. 2013;33:262–72.
11. Mentha G, Majno P, Terraz S, Rubbia-Brandt L, Gervaz P, Andres A, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol. 2007;33(Suppl 2):S76–83.
12. Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH. The “liver-first approach” for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2009;52:23–30.
13. de Rosa A, Gomez D, Hossaini S, Duke K, Fenwick SW, Brooks A, et al. Stage IV colorectal cancer: outcomes following the liver-first approach. J Surg Oncol. 2013;108:444–9.
14. Jegatheeswaran S, Mason JM, Hancock HC, Siriwardena AK. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg. 2013;148:385–91.
15. van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg. 2010;97:383–90.
16. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, et al. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case–control analysis. Ann Surg Oncol. 2013;20:482–90.
17. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.
18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
19. Cellini C, Hunt SR, Fleshman JW, Birnbaum EH, Bierhals AJ, Mutch MG. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor? World J Surg. 2010;34:1102–8.
20. Lykoudis PM, O’Reilly D, Nastos K, Fusai G. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014;101:605–12.
21. Abdalla EK, Bauer TW, Chun YS, D’Angelica M, Kooby DA, Jarnagin WR. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford). 2013;15:119–30.
22. Salmenkyla S, Kouri M, Osterlund P, Pukkala E, Luukkonen P, Hyoty M, et al. Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish rectal cancer trial. ScandJ Surg. 2012;101:275–82.
23. Buchs NC, Gervaz P, Secic M, Bucher P, Mugnier-Konrad B, Morel P. Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study. Int J Colorectal Dis. 2008;23:265–70.
24. Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246:207–14.
25. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003;197:233–41.
26. Slesser AA, Simillis C, Goldin R, Brown G, Mudan S, Tekkis PP. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol. 2013;22:36–47.
27. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg. 2000;231:743–51.
28. de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, et al. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford). 2011;13:745–52.
29. Buchs NC, Gervaz P, Bucher P, Huber O, Mentha G, Morel P. Lessons learned from one thousand consecutive colonic resections in a teaching hospital. Swiss Med Wkly. 2007;137:259–64.